QUILT-3.088: NANT Pancreatic Cancer Vaccine

Condition:   Metastatic Pancreatic Cancer Interventions:   Drug: Gemcitabine;   Drug: Nab-paclitaxel;   Drug: Aldoxorubicin HCl;   Biological: ALT-803;   Biological: ETBX-011;   Biological: ETBX-021;   Biological: ETBX-051;   Biological: ETBX-061;   Biological: GI-4000;   Biological: GI-6207;   Biological: GI-6301;   Biological:  haNK;   Drug: Avelumab;   Drug: Bevacizumab;   Drug: Capecitabine;   Drug: Cyclophosphamide;   Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: Oxaliplatin Sponsor:   NantKwest, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials